Dr. Ernst Schweizer Appointed Head of Business Development at Genmab
Dr. Schweizer was most recently President of Medarex Europe and was previously the Deputy Director of Worldwide Business Development and Licensing for Novartis and Chief Scientific and Technical Adviser of Business Development and Licensing at Ciba-Geigy. He is a member of the Board of Directors at CoMab, Hyseq, Speedel and BioPharma Fund. Dr. Schweizer received his Ph.D. from the University of Stuttgart.
"Dr. Ernst Schweizer brings a wealth of industry experience and knowledge to Genmab and will be a valuable member of the senior management team," said Genmab's CEO Dr. Lisa N. Drakeman. "We look forward to him leading the business development team through what is for Genmab an exciting time of growth."
Meistgelesene News
Organisationen
Holen Sie sich die Life-Science-Branche in Ihren Posteingang
Ab sofort nichts mehr verpassen: Unser Newsletter für Biotechnologie, Pharma und Life Sciences bringt Sie jeden Dienstag und Donnerstag auf den neuesten Stand. Aktuelle Branchen-News, Produkt-Highlights und Innovationen - kompakt und verständlich in Ihrem Posteingang. Von uns recherchiert, damit Sie es nicht tun müssen.